Reckitt Benckiser Group plc (LON:RKT – Get Free Report) insider Patricia Verduin bought 135 shares of Reckitt Benckiser Group stock in a transaction dated Wednesday, October 29th. The shares were acquired at an average cost of GBX 5,867 per share, with a total value of £7,920.45.
Reckitt Benckiser Group Trading Down 0.2%
Shares of RKT stock opened at GBX 5,816 on Friday. The company has a debt-to-equity ratio of 110.26, a current ratio of 0.69 and a quick ratio of 0.46. The company has a market cap of £39.30 billion, a price-to-earnings ratio of 31.96, a PEG ratio of 1.10 and a beta of 0.09. The stock has a 50 day simple moving average of GBX 5,707.75 and a 200-day simple moving average of GBX 5,314.92. Reckitt Benckiser Group plc has a 1-year low of GBX 4,579 and a 1-year high of GBX 6,014.
Analysts Set New Price Targets
A number of equities research analysts have issued reports on the company. Berenberg Bank reduced their price target on Reckitt Benckiser Group from GBX 5,920 to GBX 5,555 and set a “hold” rating on the stock in a research report on Wednesday, August 6th. UBS Group reaffirmed a “buy” rating and issued a GBX 7,700 price target on shares of Reckitt Benckiser Group in a research report on Friday, October 17th. Deutsche Bank Aktiengesellschaft raised their target price on Reckitt Benckiser Group from GBX 5,600 to GBX 5,700 and gave the stock a “buy” rating in a research report on Friday, October 24th. Royal Bank Of Canada raised their target price on Reckitt Benckiser Group from GBX 6,000 to GBX 6,400 and gave the stock an “outperform” rating in a research report on Thursday, October 23rd. Finally, Jefferies Financial Group reissued a “hold” rating and set a GBX 5,200 target price on shares of Reckitt Benckiser Group in a research report on Thursday, October 2nd. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of GBX 6,111.
Reckitt Benckiser Group Company Profile
At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.
Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.
We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.
At Reckitt, we’re all making a real difference to people all over the world, every day.
Read More
- Five stocks we like better than Reckitt Benckiser Group
- Conference Calls and Individual Investors
- Is Beyond Meat a Buy After Meme Stock Surge? Analysts Say No
- Health Care Stocks Explained: Why You Might Want to Invest
- ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat
- What Is WallStreetBets and What Stocks Are They Targeting?
- Super Micro’s Moment of Truth: A Growth Story Under Pressure
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.
